Arvee Laboratories (India)

quarterly
yearly
ParticularsSep '22Dec '22Mar '23Jun '23Sep '23
Revenue22.8016.3212.627.699.00
Expenses20.0615.0911.957.038.72
EBITDA3.331.811.221.070.78
EBIT2.851.320.740.720.36
Profit Before Tax2.741.230.670.650.28
Net Profit2.050.920.010.490.21
Financial Ratios
Operating Profit Margin14.60%11.14%9.71%14.08%8.75%
Net Profit Margin9.01%5.66%0.08%6.45%2.36%
Earning Per Share (Diluted)1.860.840.010.440.19
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2023 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 4.5.2
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK MAHINDRA |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  BANDHAN |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  IDBI |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ |  BAJAJ